Sean Murphy
Director of Finance/CFO chez TRISALUS LIFE SCIENCES, INC.
Fortune : 5 M $ au 31/03/2024
Profil
Mr. Sean E.
Murphy, CPA, is a Chief Financial Officer & Director at TriSalus Life Sciences, Inc. and an Independent Director at Immucor, Inc. He is on the Board of Directors at TriSalus Life Sciences, Inc., Prenosis, Inc., TriSalus Operating Life Sciences, Inc., Viamet Pharmaceuticals Corp., Altan Pharma Ltd., Xenex Disinfection Services, Inc., Brandon Point Industries Ltd., Immucor, Inc., NeuVt Ltd., Xenex Corp.
and Malin Life Sciences Holdings Ltd.
Mr. Murphy was previously employed as an Independent Director by Radius Health, Inc., an Executive Vice President by Malin Corp.
Plc, an Independent Director by Novan, Inc., an Independent Director by Nordion (Canada), Inc., a VP-Global Licensing & New Business Development by Abbott Laboratories, and a President by Perclose, Inc. He also served on the board at Poseida Therapeutics, Inc., KNOW Bio LLC and Melinta Subsidiary Corp.
He received his undergraduate degree from Western Illinois University and a graduate degree from the University of Illinois At Urbana–Champaign.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/04/2024 | 536 023 ( 2,03% ) | 5 M $ | 31/03/2024 |
Postes actifs de Sean Murphy
| Sociétés | Poste | Début |
|---|---|---|
| IMMUCOR, INC. | Director/Board Member | 01/12/2011 |
| TRISALUS LIFE SCIENCES, INC. | Director of Finance/CFO | 10/08/2023 |
NeuVt Ltd.
 NeuVt Ltd. MiscellaneousMiscellaneous NeuVt Ltd. is a private company headquartered in Dublin, Ireland. The firm functions as an investment holding company. | Director/Board Member | - |
Prenosis, Inc.
 Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Director/Board Member | 05/10/2022 |
| Xenex Corp. | Director/Board Member | - |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Director/Board Member | 05/10/2021 |
Xenex Disinfection Services, Inc.
 Xenex Disinfection Services, Inc. Medical SpecialtiesHealth Technology Xenex Disinfection Services, Inc. provides ultraviolet room disinfection systems for healthcare facilities. The firm's patented pulsed xenon UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities and due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The company eliminates harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. The company was founded by Julie A. Stachowiak, Brian Cruver and Mark Stibich in August 2008 and is headquartered in San Antonio, TX. | Director/Board Member | 01/01/2015 |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Director/Board Member | 01/10/2017 |
Altan Pharma Ltd.
 Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The private company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | Director/Board Member | 01/03/2015 |
| ░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Sean Murphy
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Sean Murphy
| Western Illinois University | Undergraduate Degree |
| University of Illinois At Urbana–Champaign | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| NVN LIQUIDATION, INC. | Health Technology |
| MALIN CORPORATION PLC | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| TRISALUS LIFE SCIENCES, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Immucor, Inc.
 Immucor, Inc. Medical SpecialtiesHealth Technology Immucor, Inc. develops, manufactures and sells transfusion and transplantation diagnostics products. It engages in the development, manufacture, and sale of products used by hospital blood banks, clinical laboratories, and blood donor centers to detect and identify certain properties of human blood prior to patient transfusion. The company was founded on May 19,1982 and is headquartered in Norcross, GA. | Health Technology |
Perclose, Inc.
 Perclose, Inc. Medical SpecialtiesHealth Technology Perclose, based in Menlo Park, Calif., designs, manufactures and markets less invasive medical devices that automate the surgical closure or connection of blood vessels. | Health Technology |
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Health Technology |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Health Technology |
Xenex Disinfection Services, Inc.
Xenex Disinfection Services, Inc. Medical SpecialtiesHealth Technology Xenex Disinfection Services, Inc. provides ultraviolet room disinfection systems for healthcare facilities. The firm's patented pulsed xenon UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities and due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The company eliminates harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. The company was founded by Julie A. Stachowiak, Brian Cruver and Mark Stibich in August 2008 and is headquartered in San Antonio, TX. | Health Technology |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Health Services |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The private company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | Health Technology |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The private company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Finance |
KNOW Bio LLC
 KNOW Bio LLC Pharmaceuticals: MajorHealth Technology KNOW Bio LLC engages in the development and optimization of a nitric oxide platform providing therapies that focuses on curing diseases and conditions. The company was founded in 2015 and is headquartered in Durham, NC. | Health Technology |
NeuVt Ltd.
NeuVt Ltd. MiscellaneousMiscellaneous NeuVt Ltd. is a private company headquartered in Dublin, Ireland. The firm functions as an investment holding company. | Miscellaneous |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Technology Services |
| Xenex Corp. |
